| Literature DB >> 35945770 |
Hadaya Mosaad Eladl1,2, Safaa M Elkholi3, Marwa M Eid2,4, Walid Kamal Abdelbasset5,6, Zeinab A Ali1,2, Heba A Bahey El-Deen7.
Abstract
OBJECTIVES: To evaluate the effectiveness of adding a supervised physical therapy exercise program to photobiomodulation therapy (PBMT) in the treatment of cervicogenic somatosensory tinnitus (CST).Entities:
Mesh:
Year: 2022 PMID: 35945770 PMCID: PMC9351917 DOI: 10.1097/MD.0000000000029946
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1.The flowchart of the study.
Basic characteristics of participants.
| Group A | Group B | ||
|---|---|---|---|
| Age (y) | 41.25 ± 7.22 | 40.8 ± 8.08 | .85 |
| Sex n (%) | |||
| Male | 13 (65%) | 10 (50%) | .33 |
| Female | 7 (35%) | 10 (50%) | |
| Affected sides n (%) | .42 | ||
| Bilateral | 15 (75%) | 17 (85%) | |
| Unilateral | 5 (25%) | 3 (15%) |
Mean VAS and THI pre- and posttreatment of the Group A and B.
| Group A | Group B | MD (95% CI) | ||
|---|---|---|---|---|
| VAS | ||||
| Pretreatment | 7.44 ± 0.69 | 7.25 ± 0.71 | 0.19 (−0.25:0.64) | .38 |
| Posttreatment | 3.6 ± 0.82 | 5.65 ± 1.13 | −2.05 (−2.68: −1.41) | .001 |
| MD (95% CI) | 3.84 (3.3: 4.38) | 1.6 (1.05: 2.14) | ||
| | .001 | .001 | ||
| THI | ||||
| Pretreatment | 46.3 ± 7.61 | 45.9 ± 8.23 | 0.4 (−4.67:5.47) | .87 |
| Posttreatment | 31.05 ± 4.43 | 36.4 ± 5.4 | −5.35 (−8.51: −2.19) | .001 |
| MD (95% CI) | 15.25 (11.77: 18.73) | 9.5 (6.01: 12.98) | ||
| | .001 | .001 | ||
Mean neck ROM pre- and posttreatment of the Group A and B.
| ROM (degrees) | Group A | Group B | MD (95% CI) | |
|---|---|---|---|---|
| Flexion | ||||
| Pretreatment | 40.1 ± 5.3 | 39.75 ± 4.17 | 0.35 (−2.7:3.4) | .81 |
| Posttreatment | 50 ± 2.1 | 46.35 ± 3.89 | 3.65 (1.64: 5.65) | .001 |
| MD (95% CI) | −9.9 (−12.03: −7.76) | −6.6 (−8.73: −4.46) | ||
| | .001 | .001 | ||
| Extension | ||||
| Pretreatment | 53.85 ± 14 | 54.8 ± 9.83 | −0.95 (−8.69:6.79) | .8 |
| Posttreatment | 74.75 ± 6.38 | 68.2 ± 9.55 | 6.55 (1.35: 11.75) | .01 |
| MD (95% CI) | −20.9 (−26.19: −15.6) | −13.4 (−18.69: −8.1) | ||
| | .001 | .001 | ||
| Right bending | ||||
| Pretreatment | 36.95 ± 4.12 | 35.8 ± 3.63 | 1.15 (-1.33:3.63) | .35 |
| Posttreatment | 44.55 ± 1.27 | 40.75 ± 2.53 | 3.8 (2.51: 5.08) | .001 |
| MD (95% CI) | −7.6 (−9.44: −5.75) | −4.95 (−6.79: −3.1) | ||
| P value | .001 | .001 | ||
| Left bending | ||||
| Pretreatment | 36.2 ± 4.55 | 36.25 ± 3.64 | −0.05 (−2.68:2.58) | .97 |
| Posttreatment | 43.65 ± 2.2 | 41.9 ± 2.63 | 1.75 (0.19: 3.3) | .02 |
| MD (95% CI) | −7.45 (−9.01: −5.89) | −5.65 (−7.21: −4.09) | ||
| P value | .001 | .001 | ||
| Right rotation | ||||
| Pretreatment | 62.1 ± 8.38 | 60.6 ± 9.08 | 1.5 (−4.09:7.09) | .59 |
| Posttreatment | 70 ± 1.62 | 66.5 ± 4.61 | 3.5 (1.28: 5.71) | .003 |
| MD (95% CI) | −7.9 (−11.27: −4.52) | −5.9 (−9.27: −2.52) | ||
| P value | .001 | .001 | ||
| Left rotation | ||||
| Pretreatment | 62.7 ± 7.06 | 60.8 ± 6.23 | 1.9 (−2.36:6.16) | .37 |
| Posttreatment | 70.25 ± 2.55 | 67.5 ± 3.8 | 2.75 (0.67: 4.82) | .01 |
| MD (95% CI) | −7.55 (−10.35: −4.74) | −6.7 (−9.5: −3.89) | ||
| | .001 | .001 | ||